BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8470148)

  • 1. Circulation in liver disease.
    Blendis LM
    Transplant Proc; 1993 Apr; 25(2):1741-3. PubMed ID: 8470148
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences.
    Groszmann RJ
    Hepatology; 1994 Nov; 20(5):1359-63. PubMed ID: 7927273
    [No Abstract]   [Full Text] [Related]  

  • 3. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule.
    Iwakiri Y; Groszmann RJ
    Hepatology; 2006 Feb; 43(2 Suppl 1):S121-31. PubMed ID: 16447289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiac output in hepatic disorders].
    Versteeg P; Palsma DM; Schalm L
    Rev Int Hepatol; 1965; 15(4):691-7. PubMed ID: 5832096
    [No Abstract]   [Full Text] [Related]  

  • 5. Splanchnic and systemic vasodilatation: the patient.
    Tsai MH
    J Clin Gastroenterol; 2007; 41 Suppl 3():S266-71. PubMed ID: 17975476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of shunt fractions pre- and post-liver transplantation.
    Barry S; Pingleton S; Kindscher J; Eisenach J; Forster J
    Transplant Proc; 1993 Apr; 25(2):1801. PubMed ID: 8470170
    [No Abstract]   [Full Text] [Related]  

  • 7. Vascular deterioration in cirrhosis: the big picture.
    Bosch J
    J Clin Gastroenterol; 2007; 41 Suppl 3():S247-53. PubMed ID: 17975472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ascites and hepatorenal syndrome: pathogenesis and treatment strategies.
    Ginès P; Arroyo V; Rodés J
    Adv Intern Med; 1998; 43():99-142. PubMed ID: 9506180
    [No Abstract]   [Full Text] [Related]  

  • 9. The kidney in chronic liver disease: circulatory abnormalities, renal sodium handling and role of natriuretic peptides.
    Valdivieso A
    Biol Res; 1998; 31(3):291-304. PubMed ID: 9830517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Liver cirrhosis and cardiovascular system].
    Ponte E; Cafagna D
    Minerva Med; 1996 Jun; 87(6):299-310. PubMed ID: 8700359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New aspects of the pathogenesis of hantavirus infections. A systemic disease with general vascular changes].
    Linderholm M; Sandström T; Tärnvik A
    Lakartidningen; 1999 Apr; 96(17):2083-6. PubMed ID: 10354671
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathophysiology of liver circulation with an overview of medical and invasive treatments.
    Bombardieri G; Conti LR
    Rays; 1997; 22(2):196-210. PubMed ID: 9351328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous measurement of effective hepatic blood flow and systemic circulation.
    Hashimoto M; Watanabe G
    Hepatogastroenterology; 2000; 47(36):1669-74. PubMed ID: 11149029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential response of the systemic and pulmonary circulation related to disease severity of cirrhosis.
    Acosta F; Sansano T; Palenciano CG; Domenech P; Falcon L; Robles R; Bueno FS; Ramirez P; Parrilla P
    Transplant Proc; 2005 Nov; 37(9):3889-90. PubMed ID: 16386574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic models including the Child-Pugh, MELD and Mayo risk scores--where are we and where should we go?
    Christensen E
    J Hepatol; 2004 Aug; 41(2):344-50. PubMed ID: 15288486
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular pathogenesis of liver disease in alpha1-antitrypsin deficiency.
    Teckman JH; Qu D; Perlmutter DH
    Hepatology; 1996 Dec; 24(6):1504-16. PubMed ID: 8938188
    [No Abstract]   [Full Text] [Related]  

  • 17. Liver-kidney pathophysiological interrelationships in liver diseases.
    Gentilini P; La Villa G
    Dig Liver Dis; 2008 Dec; 40(12):909-19. PubMed ID: 18621592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation and fibrinolysis in individuals with advanced liver disease.
    Van Thiel DH; George M; Mindikoğlu AL; Baluch MH; Dhillon S
    Turk J Gastroenterol; 2004 Jun; 15(2):67-72. PubMed ID: 15334312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxygen: modulator of metabolic zonation and disease of the liver.
    Jungermann K; Kietzmann T
    Hepatology; 2000 Feb; 31(2):255-60. PubMed ID: 10655244
    [No Abstract]   [Full Text] [Related]  

  • 20. Natural history models for hepatitis C-related liver disease: different disease progression parameters for different settings.
    Dore GJ; Freeman AJ; Law M; Kaldor JM
    Antivir Ther; 2003 Oct; 8(5):365-72. PubMed ID: 14640382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.